Erythropoietin exerts direct immunomodulatory effects on the cytokine production by activated human T-lymphocytes
- 18 May 2016
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 36, 277-281
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergenEuropean Clinical Respiratory Journal, 2015
- Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patientsExperimental Hematology, 2013
- The pleiotropic effects of erythropoietin in infection and inflammationMicrobes and Infection, 2012
- Erythropoietin receptor is detectable on peripheral blood lymphocytes and its expression increases in activated T lymphocytesHaematologica, 2011
- Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAEPLOS ONE, 2008
- Treatment with recombinant human erythropoietin is associated with rejuvenation of CD8+ T cell compartment in chronic renal failure patientsNephrology Dialysis Transplantation, 2007
- Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptorProceedings of the National Academy of Sciences, 2004
- Molecular Biology of ErythropoietinInternal Medicine, 2004
- Recombinant Human Erythropoietin Stimulates Production of Interleukin 2 by Whole Blood Cell Cultures of Hemodialysis PatientsArtificial Organs, 1999
- Immunomodulatory action of human recombinant erythropoietin in manImmunology Letters, 1993